Gemcitabine Plus Cisplatin for the Treatment of Metastatic Breast Cancer
- 1 May 2002
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 3, S24-S29
- https://doi.org/10.3816/cbc.2002.s.006
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancerAnti-Cancer Drugs, 1999
- Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancerAnti-Cancer Drugs, 1999
- Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.Journal of Clinical Oncology, 1998
- Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimensCancer, 1998
- 664: Phase II study of gemcltablne in patients with metastatic breast cancerEuropean Journal Of Cancer, 1997
- Activity of gemcltabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containlng regimensEuropean Journal Of Cancer, 1997
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- Is cisplatin useful for breast cancer?European Journal of Cancer and Clinical Oncology, 1987
- A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer two dose schedulesZeitschrift für Krebsforschung und Klinische Onkologie, 1984
- Cisplatin in the treatment of metastatic breast carcinoma A prospective randomized trial of two dosage schedulesAmerican Journal of Clinical Oncology, 1982